Conatus Pharmaceuticals Receives $5,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b649cad8-9789-4897-a5ad-13d9792d0258&Preview=1
Date
10/29/2010
Company Name
Conatus Pharmaceuticals
Mailing Address
4365 Executive Drive San Diego, CA 92121
Company Description
The Conatus team pioneered the science of apoptosis and the clinical development of pan caspase inhibitors, validating this first-in-class technology. Conatus has well established relationships with key opinion leaders in the fields of hepatology, infectious disease and inflammation.
Website
http://www.conatuspharma.com
Transaction Type
Debt
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed